PDGFRA and glioblastoma: In fact, Szerlip et al. have shown the coexistence of multiple RTK abnormalities in the same glioblastomas; 43% of PDGFRA-amplified glioblastomas were shown to have concomitant EGFR or MET amplifications [12].